News

The Management Board of Nestmedic S.A. with its registered office in Warsaw (hereinafter the “Company”, the “Issuer”) hereby submits, attached hereto, the separate and consolidated quarterly report for Q1 2026. Detailed legal basis: § 5 sec. 1 item 1 of Appendix No. 3 to the Rules of the Alternative Trading System “Current and Periodic Information Provided in the Alternative Trading System on the NewConnect Market”

13052026-Nestmedic-Q1-2026.pdf

The Management Board of Nestmedic S.A. with its registered office in Warsaw (hereinafter the “Company”, the “Issuer”) hereby submits, attached hereto, the separate and consolidated quarterly report for Q4 2025.

Detailed legal basis: § 5 sec. 1 item 1 of Appendix No. 3 to the Rules of the Alternative Trading System “Current and Periodic Information Provided in the Alternative Trading System on the NewConnect Market”

13.02.2026-Nestmedic-quarterly-report-Q4.2025.pdf


Jacek Gnich – President of the Management Board
Beata Turlejska – Vice-President of the Management Board

The Management Board of Nestmedic S.A. with its registered office in Warsaw (hereinafter the “Company”, the “Issuer”) hereby submits, attached hereto, the separate and consolidated quarterly report for Q3 2025. Legal basis: § 5 sec. 1 item 1 of Appendix No. 3 to the Rules of the Alternative Trading System “Current and Periodic Information Provided in the Alternative Trading System on the NewConnect Market”

Jacek Gnich – President of the Management Board
Beata Turlejska – Vice-President of the Management Board

Attachments:
10.11.2025 Nestmedic quarterly report Q3.pdf